Skip to main content

Interferon Alfa-2b (International)

In the US, Interferon Alfa-2b (interferon alfa-2b systemic) is a member of the drug class antineoplastic interferons and is used to treat Angioblastoma, Condylomata Acuminata, Conjunctival Mucosa-Associated Lymphoid Tissue Lymphoma, Follicular Lymphoma, Hairy Cell Leukemia, Hepatitis B, Hepatitis C, Immune Thrombocytopenia, Kaposi's Sarcoma and Melanoma.

US matches:

Scheme

USAN

ATC (Anatomical Therapeutic Chemical Classification)

L03AB05,S01AD05

CAS registry number (Chemical Abstracts Service)

0099210-65-8

Chemical Formula

C860-H1353-N229-O255-S9

Molecular Weight

19269

Therapeutic Categories

Antineoplastic agent

Antiviral agent: Treatment of hepatitis

Biological response modifier, BRM

Immunomodulator

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs